Data as of Q4 2025 (Dec 31, 2025)
⏳
Showing Q2 2024 data
Geisinger Health's Q4 2025 filing not yet available. Expected by Feb 14, 2026.

Geisinger Health

•CIK: 1946205•Filing: Q2 2024

**Geisinger Health** manages $344M across a concentrated portfolio of five holdings. The strategy exhibits a significant allocation to fixed income, anchored by AGG at $148.5M and RSP at $93.4M. Further diversification is provided through HYG ($84.6M) and international exposure via IEMG ($15.1M). This structure suggests a core focus on income-generating, fixed-income assets.

Total AUM
$344.1M
QoQ Performance
-4.1%
Positions
3
Top 10 Concentration
100.0%
Latest Filing
Q2 2024

Top Holdings Allocation

AGG
RSP
HYG
AGG43.2%
RSP27.1%
HYG24.6%
IEMG4.4%
EFV0.7%

📈 Biggest Buys

RSP
INVESCO EXCHANGE TRADED FD T
NEW
27.1% of portfolio
AGG
ISHARES TR
+0.9%
43.2% of portfolio
HYG
ISHARES TR
+1.6%
24.6% of portfolio
IEMG
ISHARES INC
+1.0%
4.4% of portfolio

📉 Biggest Sells

EFV
ISHARES TR
-70.1%
0.7% of portfolio

Sector Breakdown

Other100.0%

🚪 Exited Positionssold since Q1 2024

IWB
INVESCO EXCHANGE TRADED FD T
SOLD
$103.3M

Changes from Q1 2024

NEW1 new position
↑3 increased
↓1 decreased

Historical Filings

Q2 2024Q1 2024Q4 2023

📌 Top Holdings

AGG43.2%
ISHARES TR
$148.5M
RSP27.1%
INVESCO EXCHANGE TRADED FD T
$93.4M
HYG24.6%
ISHARES TR
$84.6M
IEMG4.4%
ISHARES INC
$15.1M
EFV0.7%
ISHARES TR
$2.5M

⚖️ Compare Fund

Compare this fund's holdings with other hedge funds.

🎯 Fund Movement Signals

See AI-analyzed fund movement signals and accumulation patterns.

👤 Insider Trading

See what corporate insiders are buying and selling.